Literature DB >> 3925739

Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease.

T M Anderson, R A Meyer, S Kaplan.   

Abstract

The long-term effects of Kawasaki disease on the cardiac function were evaluated in 67 patients. Serial M-mode echocardiograms were obtained at the time of the initial diagnosis, 1 to 3 months, at 3 to 12 months, and at greater than 12 months following the diagnosis. Left ventricular and left atrial dimensions, shortening fraction, left and right ventricular systolic time interval ratios, and computer analysis of digitized echoes of the left ventricular chamber and posterior wall were obtained. The left atrial and left ventricular dimensions were abnormal in half of the patients throughout the study periods. The shortening fraction was abnormal initially but became normal by the end of 3 months. The peak rates of emptying of the left ventricle and thickening of the posterior wall were significantly reduced in all evaluation periods. In addition, the peak rate of diastolic thinning of the posterior wall was reduced, although the peak rate of filling remained normal. Finally, more than 30% of patients studied beyond 12 months had a prolonged major filling and thinning period. There was no difference between patients with or without coronary artery aneurysms. All other systolic and diastolic phase intervals and rates of changes were normal. Contrary to previously published reports, we conclude that patients with Kawasaki disease who do not have demonstrable coronary artery disease, exhibit abnormalities of cardiac chamber size and function long after their acute illness.

Entities:  

Mesh:

Year:  1985        PMID: 3925739     DOI: 10.1016/0002-8703(85)90523-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  Anesthetic management of the patient with a history of Kawasaki disease--a report of 19 cases.

Authors:  Y Kojima; Y Kitahara; F Nozaki
Journal:  J Anesth       Date:  1990-04       Impact factor: 2.078

2.  Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease.

Authors:  Beth F Printz; Lynn A Sleeper; Jane W Newburger; L LuAnn Minich; Timothy Bradley; Meryl S Cohen; Deborah Frank; Jennifer S Li; Renee Margossian; Girish Shirali; Masato Takahashi; Steven D Colan
Journal:  J Am Coll Cardiol       Date:  2011-01-04       Impact factor: 24.094

3.  Evaluation of left ventricular systolic strain in children with Kawasaki disease.

Authors:  Qiu-Qin Xu; Yue-Yue Ding; Hai-Tao Lv; Wan-Ping Zhou; Ling Sun; Jie Huang; Wen-Hua Yan
Journal:  Pediatr Cardiol       Date:  2014-05-25       Impact factor: 1.655

4.  Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease.

Authors:  Daniel Phadke; Sonali S Patel; Samuel R Dominguez; Heather Heizer; Marsha S Anderson; Mary P Glode; Pei-Ni Jone
Journal:  Pediatr Cardiol       Date:  2015-05-21       Impact factor: 1.655

Review 5.  Long-term cardiac sequelae of Kawasaki disease.

Authors:  D R Fulton; J W Newburger
Journal:  Curr Rheumatol Rep       Date:  2000-08       Impact factor: 4.592

6.  Cardiovascular Outcomes During Index Hospitalization in Children with Kawasaki Disease in Ontario, Canada.

Authors:  Cal Robinson; Megan Schlorff; Rahul Chanchlani; Anastasia Gayowsky; Elizabeth Darling; Tapas Mondal; Hsien Seow; Michelle Batthish
Journal:  Pediatr Cardiol       Date:  2022-09-08       Impact factor: 1.838

7.  Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease.

Authors:  Matthew A Crystal; Sumeet K Syan; Rae S M Yeung; Anne I Dipchand; Brian W McCrindle
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

8.  Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.

Authors:  Nagib Dahdah; Ana Siles; Anne Fournier; Jocelyne Cousineau; Edgard Delvin; Claire Saint-Cyr; Linda Spiegelblatt; Yvette Bonny; Michèle Vartian; Martine Montigny
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

9.  Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in kawasaki disease.

Authors:  Brookie M Best; Jane C Burns; John DeVincenzo; Stephanie J Phelps; Jeffrey L Blumer; John T Wilson; Edmund V Capparelli; James D Connor
Journal:  Curr Ther Res Clin Exp       Date:  2003-02

10.  The Relationship between Coronary Artery Aneurysm and QT Interval Dispersion in Acute Phase of Kawasaki Disease.

Authors:  Abdolrazagh Kiani; Sima Rafieyian; Shahla Roodpeyma; Maryam Sefidgarnia
Journal:  Iran J Pediatr       Date:  2011-06       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.